Intralink’s Surrogate Sales Program™ is a proven and practical solution for companies seeking to gain traction, build sales bandwidth and accelerate the time to revenue in the East Asian markets of Japan, China, Taiwan and Korea. The three‐stage approach reduces cost and risk by allowing companies to overcome the cultural, structural and commercial barriers in these difficult but strategically‐important markets, and to generate revenue and gain practical insight before committing to a tie‐up with a local partner or an investment in a local subsidiary.

What are the benefits?

The Surrogate Sales Program™ offers all of the benefits of your own sales office in Japan, China or Korea – and the additional benefits of immediacy, scalability and flexibility –without the costs or risks associated with setting up and operating in a new market.

Who's it for?

For companies looking for an accelerated and low‐risk way to sell or license into the Japanese, Chinese, Taiwanese and Korean markets. Intralink has worked in a surrogate sales role for over one hundred US and European companies. Many of these are venture‐funded technology companies targeting the telecommunications, consumer electronics or enterprise sectors, but we have also worked in the healthcare, automotive, construction, chemicals, retail and other sectors.